Digital-Pathology-Today

Here is May's Digital Patholog Roundup with Imogen Fitt of Signify Research. 1. Digital Pathology as a Service (DPaaS): Histofy and Source BioScience announced a strategic partnership to enhance diagnostic workflows...

April’s Digital pathology Roundup with Imogen Fitt of Signify Research reflects strong momentum in digital pathology integrations, global AI expansion, and regulatory milestones. Partnerships & Integrations: Visiopharm...

March saw major developments across digital pathology, including regulatory milestones, foundational AI models, strategic partnerships, and significant funding wins. Regulatory Approvals: Epredia earned FDA 510(k)...

February 2025 saw significant momentum in Digital Pathology, marked by strategic partnerships, platform expansions, and regulatory progress. Here is the February Round-up with Imogen Fitt of Signify Research. Indica...

Here is January’s Digital Pathology round-up with Imogen Fitt of Signify Research. FDA Clearances: Paige received FDA 510(k) clearance for its FullFocus™ digital pathology viewer to support additional scanners, the...

Imogen Fitt from Signify Research joins us for her predictions for Digital Pathology in 2025. Trend 1 – Genomics and Digital Pathology Markets Becoming Inextricably Linked Genomics and digital pathology are converging...

Happy Holidays Everyone! Here is the Digital Pathology Round-Up covering events in November with Imogen Fitt of Signify Research. There will be no December roundup but rather an assessment of the state of the industry...

Imogen Fitt from Signify Research joins us for the October Digital Pathology Roundup, which highlights significant developments in digital pathology and related fields, focusing on funding, telepathology, generative AI...

September's round-up highlights significant advancements in AI integration, structured reporting, real-world data (RWD), hematology, and funding in the digital pathology space. Aiforia Technologies partnered with...

Imogen Fitt from Signify Research joins us to recap the news and events of August. Paige recently announced several key changes, starting with the appointment of Razik Yousfi as the new CEO. Paige is transitioning its...

The July Digital Pathology Round-up with Imogen Fitt of Signify Research is here. Nucleai and Proscia Partnership: Nucleai and Proscia have partnered to integrate Nucleai's AI Predictive Biomarker algorithms into...

A lot to talk about in June… ZayaAI introduced a Pathology Laboratory Information System (LIS), addressing integration issues between digital pathology IMS and outdated lab software. The acquisition of Visonex by...

Moving digital pathology to the cloud. We're talking about cloud computing the features and components of the cloud and how it differs from on premise computing. What are the barriers and overlooked considerations in...

Today we are discussing how treatment decisions can be personalized through artificial intelligence and digital pathology. Our guest is Andre Esteva of Artera. Atera’s first product is in prostate cancer. We discuss how...

What is pathology 3.0? We are at an inflection point. The demand on pathologists in laboratory medicine is greater than ever. Demographics and healthcare needs of the population are shifting. New technologies such as...